Home » Newsletters » BioWorld Asia

BioWorld Asia

March 4, 1998

View Archived Issues

Patent Protections In Europe Move Closer To Implementation

Scotia Drops Amelorad; Seeks Up To £50M In Funding

Milestone Medica Will Target Early-Stage Canadian Research

Parkinson's Gene Discovery Yields Clues To Pathogenesis

Oxford BioMedica Raising £6M To Fund Clinical Development

Chlorophyll Derivative Targets Improved Anticancer PDT

Trinity College Genetics Institute Opening At Cost Of IEP12M

Monsanto Plans Five More Trials Of Modified Crops In Ireland

EU Biotech Committee Handling Ambitious Workload In '98

EU Promoting Ties Between Scientists, Venture Capitalists

Other News to Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.